Decentralized Clinical Trials

Curavit is purpose-built to deliver the future of clinical research to innovative clients in biotech, academic research, and digital therapeutics.

Decentralized Clinical Trials

Digital First Design

To realize the potential of decentralized clinical trials, Curavit teams up with leading research experts in their fields.

Digital First Design

Testimonials

Testimonial – Lark Health

“Curavit’s … innovative methods of engaging patients helped us reach our goal. Plus, their fast patient enrollment supports our mission to help patients predisposed to a life-threatening condition or illness.” 
– OraLee Branch, Director of Clinical Studies at Lark Health (Curavit client)

Testimonial – MedRhythms

Curavit’s tech-enabled approach to research lets us launch quickly while delivering a premier experience for everyone involved. As important, the study will be open to participants nearly nation-wide, thanks to Curavit’s virtual site solution, patient recruitment process, and smart strategies for collecting real-world healthcare economics data.” 
– Owen McCarthy, President and co-founder of MedRhythms (Curvavit client)

Testimonial – Swing Therapeutics

“Curavit’s virtual services model enables us to efficiently recruit participants representative of the entire patient population. It solves a huge challenge and will be critical to rapidly develop the evidence needed to bring an effective digital therapy to millions suffering from chronic illness. [Additionally,] patients participating from Curavit’s site are just as engaged or even more so than the average patient in our studies in terms of compliance, patient reported outcomes, and with the digital therapeutic itself.” 
– Mike Rosenbluth, CEO at Swing Therapeutics (Curavit client)

Testimonial – Beach Tree Labs

“We chose Curavit because of their exclusive focus on designing and executing virtual trials. We needed a company with Curavit’s expertise in this important new discipline of clinical research in order to make this trial possible.” 
– Thomas Hatch, Director of BD at BeechTree Labs (Curavit client)

Testimonial – Digital Therapeutics

“Real-world evidence is critical for DTx companies to achieve coverage and reimbursement by demonstrating to payors and providers the full impact of these innovations. Curavit’s HEOR services will produce the real-world data needed to unlock wider insurance coverage and availability for transformative digital treatments. Their decentralized trials rigorously demonstrating improved outcomes and reduced costs will be instrumental to driving comprehensive adoption of these breakthrough therapies.” 
– Andy Molnar, CEO of Digital Therapeutics Alliance (Curavit partner)

Curavit has a flexible engagement model that scales based on our sponsors’ needs

Curavit’s DCT platform is the digital manifestation of our expertise. It is a HIPAA-compliant, purpose-built stack of validated and industry-proven technology, uniquely configured by our team to execute DCTs in partnership with our clients.

Curavit has a flexible engagement model that scales based on our sponsors’ needs

Curavit delivers trials through Stratus, our proprietary, industry-proven platform

Curavits’ DCT platform is the manifestation of our expertise. It is a HIPAA-compliant, purpose-built stack of validated and industry-proven technology, uniquely configured by our team to execute DCTs in partnership with our clients.

Curavit delivers trials through Stratus, our proprietary, industry-proven platform

Our Services

Curavit delivers a complete suite of CRO services, purpose-built for decentralized clinical trials. From study design and regulatory, through patient enrollment and engagement, to submission, Curavit delivers successful DCTs. Curavits services are designed to be unbundled and tailored to work with your team and your other partners.

Learn More

01. Study Design

Curavit works with world-class principal investigators to identify endpoints and create protocols from “first principles” to design studies that are digitally native.

Learn More

02. IRB Review

Curavit will manage your Institutional Review Board (IRB) process. We can work with your existing IRB or recommend an IRB for your study.

Learn More

03. Diverse Patient Recruitment

Curavit recruits participants from the 97% of potential patients who are traditionally excluded from clinical research. This is done by outlining a streamlined trial execution strategy in alignment with the trial protocol and new FDA diversity requirements. The strategy includes recommendations for optimal patient recruitment methods, technologies, and partners; community/non-profit/patient advocacy partners; preferred sites or combination of alternative sites such as mobile units and home health networks; and, tweaks to protocol designs to optimize participant enrollment across underrepresented groups.

Learn More

04. Consent & Enrollment

Curavit screens, consents, enrolls, and engages participants through Stratus, our proprietary DCT platform.

Learn More

05. Direct-to-Patient Logistics

Curavit coordinates all of the complex logistics - digital and physical - required to run a fully decentralized trial.

Learn More

06. Remote Patient Engagement

Curavit's central site supports 100% remote-based monitoring of patient activity to ensure patient safety, protocol adherence, and retention.

Learn More

07. Lab Coordination

Curavit facilitates and manages participants' external labs and integrates the results into Stratus, our proprietary DCT platform.

Learn More

08. Clinical Oversight

Curavit's clinical study teams monitor trial data in real time to ensure patient safety, protocol adherence, and patient retention. This incorporates digital consent, telehealth, and remote data capture technologies.

Learn More

09. Data Analytics

Curavit's data management team creates the statistical plan and provides full data analysis for the final study report.

Learn More

10. Regulatory

Curavit's regulatory affairs team oversees the process of getting your therapy or device through FDA review and approval and onto the market.

Learn More

Virtual Central Site

Curavit's Virtual Central Site is where patients, investigators, and Curavit's clinical study team meet to conduct research. Our Virtual Central Site lives in the cloud, is powered by Stratus - our Site platform - and replaces the brick-and-mortar sites used in traditional clinical trials.

Learn More

Our Services

Curavit delivers a complete suite of CRO services, purpose-built for decentralized clinical trials. From study design and regulatory, through patient enrollment and engagement, to submission, Curavit delivers successful DCTs. Curavits services are designed to be unbundled and tailored to work with your team and your other partners.

Learn More

Upcoming Events

Bio International: Jun 3-6, 2024

| Events | No Comments
June 3-6, 2024 | San Diego Convention Center, California

DTA Summit: June 4-7, 2024

| Events | No Comments
DTA Summit: June 4-7, 2024
DIA Anniversary 2024

DIA: June 16-20, 2024

| Events | No Comments
June 16-20, 2024 | Join us in San Diego

Member Organizations

Curavit supports organizations that align with our mission of advancing decentralized clinical trial processes and technologies to speed research and improve patients’ lives.

Curavit in the News

Opinion: Biopharma Should Prioritize Research on the Economics of Therapies

March 27, 2024
By Joel Morse

BioSpace

When biopharma companies test novel therapies in clinical trials, the primary focus of the research is on determining if the intervention works, with the goal of achieving FDA approval to enter the market. But there’s another part of clinical development that must not be neglected: health economics and outcomes research (HEOR), a multidisciplinary approach to evaluating the economic and clinical outcomes of healthcare interventions.
Read More

Contact Curavit

Let’s Talk